Where Does Regenerative Care for Nerve Pain Fit Before Surgery?

Medical professional drawing a blood sample from a patient's arm to prepare for platelet-rich plasma (PRP) therapy.

 

Somewhere after conservative care and before the operating room, and the evidence for it is thinner than most clinics admit. Nerve pain from a compressed or irritated root improves on its own far more often than people expect, which matters enormously when you’re weighing nerve pain before surgery.

This article sets out what usually happens without any intervention, what the trials on regenerative options actually found, and which symptoms mean the conversation should skip straight to a surgeon.

What Happens to Nerve Pain Without Any Treatment?

Most of it settles. Compressive nerve pain has a favorable natural history, and that baseline is the only honest way to judge any option for nerve pain before surgery, regenerative or otherwise.

What radiculopathy actually is

  • Compression or irritation of a nerve root in the spine.
  • Pain that travels along the path that nerve serves.
  • Often accompanied by numbness, tingling, or weakness.
  • Commonly caused by a disc herniation or narrowing.
  • Diagnosed clinically first, with imaging as support.
  • Distinct from muscular pain that stays in one region.

Clinical reference material defines lumbosacral radiculopathy as a pain syndrome characterized by compression or irritation of nerve roots in the lumbosacral region, which is the picture most people mean when they say sciatica.

What the recovery figures look like

  • Roughly half of cases resolve within one to two weeks.
  • Ninety percent resolve within six to twelve weeks.
  • Most cases are described in the literature as self-limited.
  • Improvement happens without injections in the large majority.
  • Symptoms can fluctuate on the way down.
  • Imaging changes lag behind how you feel.

Reference material reports that roughly half of cases resolve within 1 to 2 weeks, with 90% resolving within 6 to 12 weeks, and separately that most cases of lumbosacral radiculopathy are self-limited. That’s the number any treatment has to beat.

Why that baseline matters so much

  • Anything given during a recovering phase looks effective.
  • Testimonials rarely account for natural improvement.
  • Uncontrolled studies inherit exactly the same problem.
  • A treatment must outperform doing nothing to justify paying.
  • Timing your decision changes what you credit the result to.
  • Knowing the baseline puts you in charge of the conversation.

New to RxWellness? Your first visit, including consultation, examination, and treatment, is just $19. Book your new patient appointment today.

Related: Nerve Pain Treatment for Tingling, Numbness, and Weakness

What Does Regenerative Care Actually Include?

It covers several different things that get marketed as one. Platelet-rich plasma, prolotherapy, and cell-based products carry separate evidence bases and separate regulatory positions, and lumping them together is how people researching nerve pain before surgery get misled.

The main categories people encounter

  • Platelet-rich plasma prepared from your own blood.
  • Prolotherapy using irritant solutions to provoke repair.
  • Cell-based or stem cell products from various sources.
  • Exosome and related biological preparations.
  • Epidural versus targeted peripheral delivery routes.
  • Combination protocols bundled with rehabilitation.

What the FDA position is

  • Most marketed regenerative products are not FDA-approved.
  • The approved stem cell products are narrow in scope.
  • Approval covers blood-forming cells from umbilical cord blood.
  • Marketing of unapproved products remains widespread.
  • Regulatory status differs between PRP and cell products.
  • Being sold something isn’t evidence that it works.

The FDA states that the only stem cell products approved for use in the United States consist of blood-forming stem cells derived from umbilical cord blood, and that there continues to be broad marketing of unapproved regenerative products. Nothing on that approved list is a spine treatment.

Questions worth asking any provider

  • Which specific product is being proposed, by name?
  • Is it FDA approved for this use, or not?
  • What does the evidence show for nerve pain before surgery?
  • What was the comparison group in those studies?
  • What happens if you wait another six weeks instead?
  • What is the total cost, and what does insurance cover?

Related: How Does Regenerative Medicine Work?

What Does the Evidence Show for PRP in Nerve Pain?

Mixed, and weaker than the marketing suggests. For nerve pain before surgery, the better-designed comparisons find PRP roughly equivalent to an epidural steroid rather than better, and the reviews rate their own certainty as very low.

What the head-to-head trials found

  • A 2025 meta-analysis pooled five randomized controlled trials.
  • Those trials covered 310 patients across both arms.
  • Epidural PRP performed comparably to steroid injection.
  • The authors state plainly that it wasn’t superior.
  • Sample sizes across this literature remain small.
  • No trial in that set compared PRP against placebo alone.

That 2025 meta-analysis concluded that epidural PRP offers comparable benefit and explicitly not superior benefit to epidural steroid injection for radiculopathy from lumbar disc disease, drawing on 5 RCTs including 310 patients.

How certain that evidence is

  • A 2022 systematic review included twelve studies.
  • Only three of those twelve were randomized controlled trials.
  • The review’s own GRADE rating was very low certainty.
  • Risk of bias, indirectness, and imprecision all contributed.
  • Very low certainty means later studies may reverse it.
  • Certainty ratings rarely appear in clinic marketing.

The 2022 review reported very-low certainty of evidence because of risk of bias, indirectness, and imprecision, across twelve studies of which only three were randomized. We’d rather you hear that from us than discover it afterward.

Where steroid still holds an edge

  • A separate 2025 meta-analysis included seven studies.
  • Those studies comprised 416 patients in total.
  • Corticosteroid showed significant early functional improvements.
  • That early advantage went to steroid, not to PRP.
  • Longer-term differences were less consistent between them.
  • Neither option addresses why the nerve got compressed.

A 2025 meta-analysis in the Journal of Orthopaedic Surgery and Research reported that compared to PRP, corticosteroid injections showed significant early functional improvements, across seven studies comprising 416 patients.

If you’re ready to find lasting relief from nerve pain, our team at RxWellness is here to help. Call the nearest RxWellness Spine and Health clinic to schedule your consultation today.

Related: Sciatica Pain Relief: Treatments for Soothing Sciatic Nerve Pain

Does Waiting Make Surgery Less Effective Later?

Generally no, for the common presentations. A landmark randomized trial compared early surgery against prolonged conservative care for sciatica and found the two paths converged, which is the most useful fact anyone weighing nerve pain before surgery can have.

What the randomized comparison found.

  • Early surgery produced faster relief of sciatica.
  • Outcomes between the groups were similar by one year.
  • That similarity held through the second year.
  • Disability scores showed no significant overall difference.
  • Speed of relief and final outcome are different questions.
  • Waiting cost time rather than the eventual result.

The 2008 trial reported that early surgery achieved more rapid relief of sciatica than conservative care, but outcomes were similar by one year and did not change during the second year, with no significant overall difference in disability scores across the first two years.

How to read that result

  • Faster relief has genuine value if pain is severe.
  • It doesn’t mean surgery produces a better end state.
  • The trade is time and discomfort against surgical risk.
  • Personal tolerance for months of pain matters here.
  • Work, caring duties, and finances all belong in the decision.
  • The finding applies to sciatica from disc herniation.

Where regenerative care sits in that window

  • It occupies the months between diagnosis and any surgery.
  • Most people improve in that window regardless.
  • Evidence places it alongside steroid rather than above it.
  • It doesn’t appear to change the eventual surgical outcome.
  • Cost is usually out of pocket, and often substantial.
  • It’s a reasonable option rather than a proven shortcut.

Our founder’s work building multidisciplinary spine care was recognized with the Life University Distinguished Alumni Award in 2025.

Related: Can Regenerative Medicine Help You Avoid Joint Replacement Surgery?

What Should Come Before Any Injection?

A medical professional holds a patient's open palm while pressing a hand-held stimulator device against the wrist. Small white electrode patches with wires are attached to the patient's palm to test for carpal tunnel or nerve pain.

Conservative care, time, and a proper diagnosis. That’s the honest sequence for nerve pain before surgery, even though the evidence for conservative care is itself less robust than clinics usually claim.

What conservative management involves

  • Staying active within the limits your symptoms allow.
  • Graded exercise that progressively loads the spine.
  • Manual therapy aimed at mechanics and muscle guarding.
  • Education about the expected recovery timeline.
  • Medication decisions made with a medical provider.
  • Regular reassessment rather than an open-ended plan.

Where that evidence stands

  • A 2023 review pooled eighteen trials on physiotherapy for sciatica.
  • Those trials included 2,699 participants in total.
  • The authors found the evidence inadequate for firm recommendations.
  • Risk of bias across the included trials was high.
  • Inadequate evidence isn’t the same as evidence of no effect.
  • This whole field needs better trials, not louder claims.

That 2023 systematic review concluded there is inadequate evidence to make clinical recommendations on the effectiveness of physiotherapy interventions for people with clinically diagnosed sciatica, drawing on 18 trials with 2,699 participants.

Why we still start here

  • Conservative care carries low risk and low cost.
  • Most nerve pain resolves during the same window.
  • It builds capacity that no injection can provide.
  • It gives a baseline against which to judge later options.
  • It keeps the surgical door completely open.
  • Nothing about it forecloses a future decision.

Comfort is the first goal and not the last one. What follows is restoring how you move, then building the strength and tolerance that keep a spine working through the decades ahead, which is the longer arc our multidisciplinary team is built around.

RxWellness has grown that combined model steadily, including when King Street Wellness joined the group in 2025.

Related: What Makes Some Physical Therapy Clinics More Effective for Back Pain?

When Is Surgery the Right Conversation Instead?

When specific findings appear. Some presentations are surgical emergencies where delay costs function permanently, and no option for nerve pain before surgery belongs anywhere near that conversation.

Findings that mean urgent surgical assessment

  • New loss of bladder or bowel control.
  • Numbness across the saddle or inner thigh region.
  • Progressive weakness rather than stable weakness.
  • Changes to your gait that keep worsening.
  • Sexual dysfunction appearing alongside the back pain.
  • Severe symptoms in both legs developing quickly.

Clinical reference material lists new-onset urinary incontinence alongside progressive weakness, saddle anesthesia, gait changes, and bowel dysfunction as concerning for cauda equina syndrome. That combination means an emergency department, not a clinic appointment.

Why the timing is so tight

  • Cauda equina and conus medullaris syndromes are neurosurgical emergencies.
  • They present with radiating pain and motor or sensory loss.
  • Bladder, bowel, and sexual dysfunction can all feature.
  • Earlier decompression is associated with better prognosis.
  • The literature points to a window around 48 hours.
  • Lost function may not return once it has gone.

Reference material describes both as neurosurgical emergencies and notes that early surgical decompression is associated with a better prognosis, particularly within 48 hours of initial presentation.

Non-emergency reasons to see a surgeon

  • Severe pain that hasn’t budged after several months.
  • Weakness that limits your daily function.
  • Symptoms worsening despite good conservative care.
  • Imaging findings that match your symptoms precisely.
  • A wish to weigh surgery against continued waiting.
  • Any situation where you want a specialist opinion.

RxWellness ranked No. 2,218 on the 2024 Inc. 5000 list of America’s fastest-growing private companies.

Related: How to Relieve Sciatica Nerve Pain

FAQs

Does PRP work better than a steroid injection for sciatica?

The best available comparison of options for nerve pain before surgery says no. A 2025 meta-analysis of five randomized trials covering 310 patients concluded that epidural PRP offers comparable and explicitly not superior benefit compared to epidural steroid injection. A separate 2025 meta-analysis of 416 patients found corticosteroid produced significant early functional improvements relative to PRP. Neither result rules PRP out, and neither supports paying a premium for it.

How long should I try conservative care before considering an injection?

Six to twelve weeks is a reasonable window, because that’s when the large majority of radiculopathy resolves anyway. Clinical reference material puts roughly half of cases resolving within one to two weeks and 90% within six to twelve. Acting inside that window makes it hard to know whether the treatment or the time did the work. Red flag symptoms change this entirely and need immediate attention.

Are stem cell injections approved for nerve pain?

No. The FDA states that the only stem cell products approved for use in the United States are blood-forming stem cells derived from umbilical cord blood, which isn’t a spine or nerve treatment. Any clinic offering stem cell therapy for radiculopathy is offering an unapproved product. That doesn’t automatically make it harmful, and it does mean you’re paying for something outside the approval system.

If I delay surgery, will I get a worse result?

For sciatica from a disc herniation, the randomized evidence says outcomes converge. The 2008 trial found early surgery produced faster relief but similar outcomes by one year, holding through the second year. So the trade is how long you’re willing to hurt, rather than a penalty on your final result. Progressive weakness or cauda equina symptoms are the exception and need urgent assessment.

Is chiropractic care safe when I have nerve pain?

For most presentations yes, after an examination that screens for red flags. Assessment should cover reflexes, strength, and sensation before anyone treats. Technique gets adapted for irritable nerve tissue, and treatment that reliably worsens leg symptoms gets changed rather than pushed through. Progressive neurological loss means referral rather than continued care.

What if my MRI shows a large disc herniation?

Imaging findings and symptoms correlate loosely, and large herniations often improve without surgery. What matters more is your neurological examination, the direction your symptoms are moving, and how much function you’re losing. A big herniation with improving symptoms is usually managed conservatively. The same image alongside progressive weakness is a different conversation entirely.

Does insurance cover regenerative injections for nerve pain?

Usually not, and that shapes the decision about nerve pain before surgery more than people expect. PRP and cell-based products for spinal conditions are commonly classified as investigational and excluded from coverage, which is why these are typically out of pocket. Ask for the total cost in writing before agreeing to anything, including how many sessions are anticipated. Then weigh that against the recovery you’d likely get from time and conservative care.

Key Takeaways

  • Half of radiculopathy cases resolve in one to two weeks, 90% within twelve.
  • The best trials find epidural PRP comparable to steroid, not superior.
  • A 2022 review rated the PRP evidence as very low certainty.
  • The FDA approves no stem cell product for spinal or nerve conditions.
  • Early surgery relieves sciatica faster, with outcomes similar by one year.
  • Cauda equina symptoms are an emergency, never a candidate for injections.
  • Weighing nerve pain before surgery works best with the natural history in view.

Find Lasting Relief From Nerve Pain Without Rushing a Decision

Regenerative care for nerve pain before surgery occupies a genuine space, and it’s a narrower one than the marketing implies. Most compressive nerve pain resolves inside twelve weeks on its own, the head-to-head trials place PRP alongside steroid rather than above it, and the reviews rate their own certainty as very low. The randomized evidence on surgery says that waiting costs time rather than the eventual outcome, provided no red flags appear. That combination argues for conservative care first, an honest look at cost and evidence before any injection, and immediate referral if bladder, bowel, or progressive weakness symptoms show up.

Relief is where this starts rather than where it ends. Rebuilding tolerance, strength, and confident movement is what keeps a spine working well into later decades, and that longer arc is what our team is designed to support.

Ready to take the next step toward recovery? Schedule your consultation online to visit RxWellness today and begin your path to relief.